Company: BDRX
Filing Date: 2025-05-12
Form Type: 424B3
Source: 0001214659-25-007341
Chunk: 103

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-12
Form: 424B3
Chunk 103
---
 3.8% Medicare
tax may be imposed on some or all of such U.S. Holder’s “net investment income.” Net investment income generally includes
income from the Depositary Shares unless such income is derived in the ordinary course of the conduct of a trade or business (other than
a trade or business that consists of certain passive or trading activities). You should consult your tax advisors regarding the effect
this Medicare tax may have, if any, on your acquisition, ownership or disposition of the Depositary Shares and the warrants.

Information Reporting and Backup Withholding

Distributions with respect
to Depositary Shares and proceeds from the sale, exchange or disposition of Depositary Shares or warrants may be subject to information
reporting to the IRS, and possible U.S. backup withholding. Backup withholding will not apply, however, to a U.S. Holder who furnishes
a correct taxpayer identification number and makes any other required certification or who is otherwise exempt from backup withholding.
U.S. Holders who are required to establish their exempt status generally must provide such certification on U.S. Internal Revenue Service
Form W-9. U.S. Holders are urged to consult their tax advisors regarding the application of the United States information reporting
and backup withholding rules.

Backup withholding is not
an additional tax. Amounts withheld as backup withholding may be credited against a U.S. Holder’s United States federal income tax
liability, and a U.S. Holder may obtain a refund of any excess amounts withheld under the backup withholding rules by filing the appropriate
claim for refund with the IRS and furnishing any required information.

| 68 |

Foreign Financial Asset Information Reporting

U.S. Holders who are either
individuals or certain domestic entities may be required to submit certain information to the IRS with respect to such holder’s
beneficial ownership of the Depositary Shares or warrants, if such Depositary Shares or warrants are not held on such holder’s behalf
by a financial institution, as our ordinary shares are considered “specified foreign financial assets.” This law also imposes
penalties and potential other adverse tax consequences if a U.S. Holder is required to submit such information to the IRS and fails to
do so. U.S. Holders are urged to consult their tax advisors regarding the potential information reporting obligations that may be imposed
with respect to the ownership and disposition of the Depositary Shares or warrants.

THE DISCUSSION ABOVE IS A GENERAL SUMMARY. IT DOES NOT COVER ALL TAX MATTERS THAT MAY BE OF IMPORTANCE TO A